Woodline Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$106M Sell
406,941
-500,422
-55% -$128M 0.32% 53
2026
Q2
$228M Buy
907,363
+561,186
+162% +$121M 0.71% 16
2026
Q1
$75.3M Buy
346,177
+149,913
+76% +$33.3M 0.28% 73
2025
Q4
$44.8M Sell
196,264
-37,197
-16% -$8.47M 0.17% 155
2025
Q3
$54.1M Sell
233,461
-95,888
-29% -$19.5M 0.25% 97
2025
Q2
$61.1M Sell
329,349
-298,745
-48% -$55.5M 0.32% 72
2025
Q1
$132M Buy
628,094
+23,036
+4% +$4.48M 0.86% 9
2024
Q4
$108M Sell
605,058
-203,678
-25% -$37.4M 0.73% 12
2024
Q3
$160M Buy
808,736
+58,414
+8% +$10.9M 1.35% 3
2024
Q2
$129M Buy
750,322
+111,929
+18% +$18.5M 1.23% 5
2024
Q1
$116M Sell
638,393
-636,304
-50% -$110M 1.07% 12
2023
Q4
$198M Buy
1,274,697
+31,351
+3% +$4.57M 2.15% 1
2023
Q3
$185M Buy
1,243,346
+822,491
+195% +$121M 2.17% 2
2023
Q2
$56.7M Sell
420,855
-59,150
-12% -$8.67M 0.67% 33
2023
Q1
$76.5M Buy
480,005
+30,431
+7% +$4.65M 1.04% 13
2022
Q4
$72.7M Buy
449,574
+262,486
+140% +$40.2M 0.97% 12
2022
Q3
$25.1M Buy
+187,088
New +$26.8M 0.35% 78
2022
Q1
– Sell
-1,070,201
Closed -$145M – 710
2021
Q4
$145M Buy
1,070,201
+289,792
+37% +$34.2M 2.08% 3
2021
Q3
$84.2M Buy
780,409
+169,879
+28% +$19.4M 1.37% 6
2021
Q2
$68.8M Buy
610,530
+469,295
+332% +$52.9M 1.28% 11
2021
Q1
$15.3M Buy
+141,235
New +$15.1M 0.34% 81

Other funds holding ABBV

Woodline Partners's ABBV Position: Q3 2026 in Review

Woodline Partners reduced its AbbVie (ABBV) stake by 55% in Q3 2026, selling an estimated $128M and leaving 406,941 shares worth $106M. The position accounts for 0.32% of the portfolio, ranked #53.

Woodline Partners first reported a position in ABBV in Q1 2021 and has held it in 21 quarters since. The position peaked at $228M in Q2 2026. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Woodline Partners held 406,941 shares of AbbVie worth $106M as of Q3 2026.
  • Woodline Partners sold 500,422 AbbVie shares in Q3 2026, an estimated $128M.
  • AbbVie made up 0.32% of Woodline Partners's portfolio in Q3 2026, its #53 holding.
  • Woodline Partners first reported a position in AbbVie in Q1 2021 and has held it in 21 quarters since.
  • Woodline Partners's AbbVie position peaked at $228M in Q2 2026.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Woodline Partners's 13F filing for Q3 2026, filed 16 Nov 2026.